Bridgewater Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-4,762
Closed -$205K – 499
2026
Q2
$205K Sell
4,762
-1,466
-24% -$65.5K 0.01% 475
2026
Q1
$264K Buy
6,228
+1,592
+34% +$74.2K 0.02% 389
2025
Q4
$214K Sell
4,636
-756
-14% -$37.5K 0.01% 430
2025
Q3
$267K Sell
5,392
-828
-13% -$40K 0.02% 374
2025
Q2
$307K Sell
6,220
-1,053
-14% -$53.8K 0.02% 332
2025
Q1
$391K Buy
+7,273
New +$394K 0.03% 275

Other funds holding SNY

Bridgewater Advisors's SNY Position: Q3 2026 in Review

Bridgewater Advisors sold out of Sanofi (SNY) in Q3 2026, closing a stake of 4,762 shares — an estimated $205K sold.

Bridgewater Advisors first reported a position in SNY in Q1 2025 and held it in 6 quarters. The position peaked at $391K in Q1 2025. 687 funds tracked by Wall St. Rank hold SNY as of Q3 2026.

  • Bridgewater Advisors reported no remaining Sanofi position as of Q3 2026 after selling out during the quarter.
  • Bridgewater Advisors sold 4,762 Sanofi shares in Q3 2026, an estimated $205K.
  • Bridgewater Advisors first reported a position in Sanofi in Q1 2025 and held it in 6 quarters.
  • Bridgewater Advisors's Sanofi position peaked at $391K in Q1 2025.
  • 687 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.

Based on Bridgewater Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.